Localization of influenza virus proteins to nuclear dot 10 structures in influenza virus-infected cells

Virology

Volumn 310, Issue 1, 2003, Pages 29-40

  Sato, Yoshiko ^a   Yoshioka, Kenichi ^a   Suzuki, Chie ^a   Awashima, Satoshi ^a   Hosaka, Yasuhiro ^a   Yewdell, Jonathan ^b   Kuroda, Kazumichi ^a,c  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c NIHON UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; MATRIX PROTEIN; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; VIRUS FUSION PROTEIN; VIRUS PROTEIN; INS1 PROTEIN, INFLUENZA VIRUS; PHOTOPROTEIN;

ANIMAL CELL; ARTICLE; CELL LINE; CELL ULTRASTRUCTURE; CELLULAR IMMUNITY; CYTOSOL; EMBRYO; FLUORESCENCE; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; INFLUENZA VIRUS A; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN LOCALIZATION; VIRUS REPLICATION; ANIMAL; CELL NUCLEUS; CHEMISTRY; DOG; HELA CELL; METABOLISM; ORTHOMYXOVIRUS; VIRION;

INFLUENZA A VIRUS; INFLUENZA B VIRUS; INFLUENZA VIRUS;

ANIMALS; CELL NUCLEUS; DOGS; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; LUMINESCENT PROTEINS; ORTHOMYXOVIRIDAE; VIRAL MATRIX PROTEINS; VIRAL NONSTRUCTURAL PROTEINS; VIRION;

EID: 0038205593     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(03)00104-1     Document Type: Article

References (77)

1. Anton L.C., Schubert U., Bacik I., Princiotta M.F., Wearsch P.A., Gibbs J., Day P.M., Realini C., Rechsteiner M.C., Bennink J.R., Yewdell J.W. Intracellular localization of proteasomal degradation of a viral antigen. J. Cell Biol. 146:1999;113-124.
2. Avalos R.T., Yu Z., Nayak D.P. Association of influenza virus NP and M1 proteins with cellular cytoskeletal elements in influenza virus-infected cells. J. Virol. 71:1997;2947-2958.
3. Bergmann M., Garcia-Sastre A., Carnero E., Pehamberger H., Wolff K., Palese P., Muster T. Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. J. Virol. 74:2000;6203-6206.
4. Booy F.P., Ruigrok R.W., van Bruggen E.F. Electron microscopy of influenza virus. A comparison of negatively stained and ice-embedded particles. J. Mol. Biol. 184:1985;667-676.
5. Bucher D., Popple S., Baer M., Mikhail A., Gong Y.F., Whitaker C., Paoletti E., Judd A. M protein (M1) of influenza virus antigenic analysis and intracellular localization with monoclonal antibodies. J. Virol. 63:1989;3622-3633.
6. Bucher D.J., Kharitonenkov I.G., Zakomirdin J.A., Grigoriev V.B., Klimenko S.M., Davis J.F. Incorporation of influenza virus M-protein into liposomes. J. Virol. 36:1980;586-590.
7. Bui M., Whittaker G., Helenius A. Effect of M1 protein and low pH on nuclear transport of influenza virus ribonucleoproteins. J. Virol. 70:1996;8391-8401.
8. Bui M., Wills E.G., Helenius A., Whittaker G.R. Role of the influenza virus M1 protein in nuclear export of viral ribonucleoproteins. J. Virol. 74:2000;1781-1786.
9. Chelbi-Alix M.K., de The H. Herpes virus induced proteasome-dependent degradation of the nuclear bodies-associated PML and Sp100 proteins. Oncogene. 18:1999;935-941.
10. Chelbi-Alix M.K., Pelicano L., Quignon F., Koken M.H., Venturini L., Stadler M., Pavlovic J., Degos L., de The H. Induction of the PML protein by interferons in normal and APL cells. Leukemia. 9:1995;2027-2033.
11. Chelbi-Alix M.K., Quignon F., Pelicano L., Koken M.H., de The H. Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein. J. Virol. 72:1998;1043-1051.
12. Crescenzo-Chaigne B., Naffakh N., van der W.S. Comparative analysis of the ability of the polymerase complexes of influenza viruses type A, B and C to assemble into functional RNPs that allow expression and replication of heterotypic model RNA templates in vivo. Virology. 265:1999;342-353.
13. Desai P., Person S. Incorporation of the green fluorescent protein into the herpes simplex virus type 1 capsid. J. Virol. 72:1998;7563-7568.
14. Desbois C., Rousset R., Bantignies F., Jalinot P. Exclusion of Int-6 from PML nuclear bodies by binding to the HTLV-I Tax oncoprotein. Science. 273:1996;951-953.
15. Doucas V., Ishov A.M., Romo A., Juguilon H., Weitzman M.D., Evans R.M., Maul G.G. Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure. Genes Dev. 10:1996;196-207.
16. Elliott G., O'Hare P. Intercellular trafficking and protein delivery by a herpesvirus structural protein. Cell. 88:1997;223-233.
17. Enami M., Enami K. Influenza virus hemagglutinin and neuraminidase glycoproteins stimulate the membrane association of the matrix protein. J. Virol. 70:1996;6653-6657.
18. Everett R.D., Maul G.G. HSV-1 IE protein Vmw110 causes redistribution of PML. EMBO J. 13:1994;5062-5069.
19. Fortes P., Lamond A.I., Ortin J. Influenza virus NS1 protein alters the subnuclear localization of cellular splicing components. J. Gen. Virol. 76:(Pt 4):1995;1001-1007.
20. Fujiyoshi Y., Kume N.P., Sakata K., Sato S.B. Fine structure of influenza A virus observed by electron cryo-microscopy. EMBO J. 13:1994;318-326.
21. Garcia-Sastre A., Egorov A., Matassov D., Brandt S., Levy D.E., Durbin J.E., Palese P., Muster T. Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology. 252:1998;324-330.
22. Ghenkina D.B., Ghendon Y.Z. Recombination and complementation between orthomyxoviruses under conditions of abortive infection. Acta Virol. 23:1979;97-106.
23. Gregoriades A. Interaction of influenza M protein with viral lipid and phosphatidylcholine vesicles. J. Virol. 36:1980;470-479.
24. Gregoriades A., Christie T., Markarian K. The membrane (M1) protein of influenza virus occurs in two forms and is a phosphoprotein. J. Virol. 49:1984;229-235.
25. Gregoriades A., Frangione B. Insertion of influenza M protein into the viral lipid bilayer and localization of site of insertion. J. Virol. 40:1981;323-328.
26. Gregoriades A., Guzman G.G., Paoletti E. The phosphorylation of the integral membrane (M1) protein of influenza virus. Virus Res. 16:1990;27-41.
27. Guldner H.H., Szostecki C., Grotzinger T., Will H. IFN enhance expression of Sp100, an autoantigen in primary biliary cirrhosis. J. Immunol. 149:1992;4067-4073.
28. Hankins R.W., Nagata K., Kato A., Ishihama A. Mechanism of influenza virus transcription inhibition by matrix (M1) protein. Res. Virol. 141:1990;305-314.
29. Hodges M., Tissot C., Howe K., Grimwade D., Freemont P.S. Structure, organization, and dynamics of promyelocytic leukemia protein nuclear bodies. Am. J. Hum. Genet. 63:1998;297-304.
30. Jambrina E., Barcena J., Uez O., Portela A. The three subunits of the polymerase and the nucleoprotein of influenza B virus are the minimum set of viral proteins required for expression of a model RNA template. Virology. 235:1997;209-217.
31. Jin H., Leser G.P., Zhang J., Lamb R.A. Influenza virus hemagglutinin and neuraminidase cytoplasmic tails control particle shape. EMBO J. 16:1997;1236-1247.
32. Koken M.H., Linares-Cruz G., Quignon F., Viron A., Chelbi-Alix M.K., Sobczak-Thepot J., Juhlin L., Degos L., Calvo F., de The H. The PML growth-suppressor has an altered expression in human oncogenesis. Oncogene. 10:1995;1315-1324.
33. Korioth F., Maul G.G., Plachter B., Stamminger T., Frey J. The nuclear domain 10 (ND10) is disrupted by the human cytomegalovirus gene product IE1. Exp. Cell Res. 229:1996;155-158.
34. Kretzschmar E., Bui M., Rose J.K. Membrane association of influenza virus matrix protein does not require specific hydrophobic domains or the viral glycoproteins. Virology. 220:1996;37-45.
35. Lamb R.A. Genes and proteins of the influenza virus. Krug R.M. The Influenza Viruses. 1989;1-87 Plenum Press, New York.
36. Lamb R.A., Krug R.M. Orthomyxoviridae the viruses and their replication. Fields B.N., Knipe D.M., Howley P.M. Fields Virology. 1996;1353-1395 Lippincott-Raven Publishers, Philadelphia.
37. Lavau C., Marchio A., Fagioli M., Jansen J., Falini B., Lebon P., Grosveld F., Pandolfi P.P., Pelicci P.G., Dejean A. The acute promyelocytic leukaemia-associated PML gene is induced by interferon. Oncogene. 11:1995;871-876.
38. Le X.F., Yang P., Chang K.S. Analysis of the growth and transformation suppressor domains of promyelocytic leukemia gene, PML. J. Biol. Chem. 271:1996;130-135.
39. Lippincott-Schwartz J., Cole N., Presley J. Unravelling Golgi membrane traffic with green fluorescent protein chimeras. Trends Cell Biol. 8:1998;16-20.
40. Liu J.H., Mu Z.M., Chang K.S. PML suppresses oncogenic transformation of NIH/3T3 cells by activated neu. J. Exp. Med. 181:1995;1965-1973.
41. Martin K., Helenius A. Nuclear transport of influenza virus ribonucleoproteins the viral matrix protein (M1) promotes export and inhibits import. Cell. 67:1991;117-130.
42. Maul G.G. Nuclear domain 10, the site of DNA virus transcription and replication. Bioessays. 20:1998;660-667.
43. Mitnaul L.J., Castrucci M.R., Murti K.G., Kawaoka Y. The cytoplasmic tail of influenza A virus neuraminidase (NA) affects NA incorporation into virions, virion morphology, and virulence in mice but is not essential for virus replication. J. Virol. 70:1996;873-879.
44. Mu Z.M., Chin K.V., Liu J.H., Lozano G., Chang K.S. PML, a growth suppressor disrupted in acute promyelocytic leukemia. Mol. Cell Biol. 14:1994;6858-6867.
45. Nermut M.V. Further investigation on the fine structure of influenza virus. J. Gen. Virol. 17:1972;317-331.
46. O'Neill R.E., Talon J., Palese P. The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins. EMBO J. 17:1998;288-296.
47. Perez D.R., Donis R.O. The matrix 1 protein of influenza A virus inhibits the transcriptase activity of a model influenza reporter genome in vivo. Virology. 249:1998;52-61.
48. Pinto L.H., Holsinger L.J., Lamb R.A. Influenza virus M2 protein has ion channel activity. Cell. 69:1992;517-528.
49. Presley J.F., Cole N.B., Schroer T.A., Hirschberg K., Zaal K.J., Lippincott-Schwartz J. ER-to-Golgi transport visualized in living cells. Nature. 389:1997;81-85.
50. Quignon F., De Bels F., Koken M., Feunteun J., Ameisen J.C., de The H. PML induces a novel caspase-independent death process. Nat. Genet. 20:1998;259-265.
51. Reinhardt J., Wolff T. The influenza A virus M1 protein interacts with the cellular receptor of activated C kinase (RACK) 1 and can be phosphorylated by protein kinase C. Vet. Microbiol. 74:2000;87-100.
52. Ruigrok R.W., Barge A., Durrer P., Brunner J., Ma K., Whittaker G.R. Membrane interaction of influenza virus M1 protein. Virology. 267:2000;289-298.
53. Schulze I.T. The structure of influenza virus. II. A model based on the morphology and composition of subviral particles. Virology. 47:1972;181-196.
54. Shapiro G.I., Gurney T. Jr., Krug R.M. Influenza virus gene expression control mechanisms at early and late times of infection and nuclear-cytoplasmic transport of virus-specific RNAs. J. Virol. 61:1987;764-773.
55. Stadler M., Chelbi-Alix M.K., Koken M.H., Venturini L., Lee C., Saib A., Quignon F., Pelicano L., Guillemin M.C., Schindler C. Transcriptional induction of the PML growth suppressor gene by interferons is mediated through an ISRE and a GAS element. Oncogene. 11:1995;2565-2573.
56. Staufenbiel M., Deppert W. Preparation of nuclear matrices from cultured cells subfractionation of nuclei in situ. J. Cell Biol. 98:1984;1886-1894.
57. Sternsdorf T., Grotzinger T., Jensen K., Will H. Nuclear dots actors on many stages. Immunobiology. 198:1997;307-331.
58. Sugrue R.J., Hay A.J. Structural characteristics of the M2 protein of influenza A viruses evidence that it forms a tetrameric channel. Virology. 180:1991;617-624.
59. Talon J., Salvatore M., O'Neill R.E., Nakaya Y., Zheng H., Muster T., Garcia-Sastre A., Palese P. Influenza A and B viruses expressing altered NS1 proteins a vaccine approach. Proc. Natl. Acad. Sci. USA. 97:2000;4309-4314.
60. Thomas C.L., Maule A.J. Limitations on the use of fused green fluorescent protein to investigate structure-function relationships for the cauliflower mosaic virus movement protein. J. Gen. Virol. 81:(Pt 7):2000;1851-1855.
61. Torii S., Egan D.A., Evans R.A., Reed J.C. Human Daxx regulates Fas-induced apoptosis from nuclear PML oncogenic domains (PODs). EMBO J. 18:1999;6037-6049.
62. Tsien R.Y. The green fluorescent protein. Annu. Rev. Biochem. 67:1998;509-544.
63. Wang Z.G., Delva L., Gaboli M., Rivi R., Giorgio M., Cordon-Cardo C., Grosveld F., Pandolfi P.P. Role of PML in cell growth and the retinoic acid pathway. Science. 279:1998;1547-1551.
64. Wang Z.G., Ruggero D., Ronchetti S., Zhong S., Gaboli M., Rivi R., Pandolfi P.P. PML is essential for multiple apoptotic pathways. Nat. Genet. 20:1998;266-272.
65. Ward A.C., Castelli L.A., Lucantoni A.C., White J.F., Azad A.A., Macreadie I.G. Expression and analysis of the NS2 protein of influenza A virus. Arch. Virol. 140:1995;2067-2073.
66. Watanabe K., Handa H., Mizumoto K., Nagata K. Mechanism for inhibition of influenza virus RNA polymerase activity by matrix protein. J. Virol. 70:1996;241-247.
67. Whittaker G., Bui M., Helenius A. Nuclear trafficking of influenza virus ribonuleoproteins in heterokaryons. J. Virol. 70:1996;2743-2756.
68. Wolff T., O'Neill R.E., Palese P. NS1-Binding protein (NS1-BP) a novel human protein that interacts with the influenza A virus nonstructural NS1 protein is relocalized in the nuclei of infected cells. J. Virol. 72:1998;7170-7180.
69. Yasuda J., Nakada S., Kato A., Toyoda T., Ishihama A. Molecular assembly of influenza virus association of the NS2 protein with virion matrix. Virology. 196:1993;249-255.
70. Ye Z.P., Baylor N.W., Wagner R.R. Transcription-inhibition and RNA-binding domains of influenza A virus matrix protein mapped with anti-idiotypic antibodies and synthetic peptides. J. Virol. 63:1989;3586-3594.
71. Zhang J., Lamb R.A. Characterization of the membrane association of the influenza virus matrix protein in living cells. Virology. 225:1996;255-266.
72. Zhao H., Ekstrom M., Garoff H. The M1 and NP proteins of influenza A virus form. J. Gen. Virol. 79:(Pt 10):1998;2435-2446.
73. Zheng P., Guo Y., Niu Q., Levy D.E., Dyck J.A., Lu S., Sheiman L.A., Liu Y. Proto-oncogene PML controls genes devoted to MHC class I antigen presentation. Nature. 396:1998;373-376.
74. Zhirnov O.P. Solubilization of matrix protein M1/M from virions occurs at different pH for ortho. Virology. 176:1990;274-279.
75. Zhirnov O.P. Isolation of matrix protein M1 from influenza viruses by acid-dependent extraction with nonionic detergent. Virology. 186:1992;324-330.
76. Zhirnov O.P., Klenk H.D. Histones as a target for influenza virus matrix protein M1. Virology. 235:1997;302-310.
77. Zvonarjev A.Y., Ghendon Y.Z. Influence of membrane (M) protein on influenza A virus virion transcriptase activity in vitro and its susceptibility to rimantadine. J. Virol. 33:1980;583-586.